-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICON-1 in Choroidal Neovascularization
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICON-1 in Choroidal Neovascularization report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
Choroidal Neovascularization – Drugs In Development, 2023
Global Markets Direct’s, ‘Choroidal Neovascularization - Drugs In Development, 2023’, provides an overview of the Choroidal Neovascularization pipeline landscape. The report provides comprehensive information on the therapeutics under development for Choroidal Neovascularization, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Norovirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Norovirus Infections - Drugs In Development, 2023’, provides an overview of the Norovirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Norovirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Sharp Makueni Solar PV Park
Sharp Makueni Solar PV Park is a solar PV project located in Makueni, Kenya. The project is owned by Legacy Energy Group LLC; Rareh Icon Solar Ltd; responsAbility Africa Ltd.; Sharp Energy Solutions Corp and is developed by Legacy Energy Group LLC; Rareh Icon Solar Ltd; Sharp Energy Solutions Corp. The project is at the permitting stage. Empower your strategies with our Sharp Makueni Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report...
-
Product Insights
Ablation Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ablation Equipment Pipeline Market Report Overview An Ablation Equipment is a device used to surgically remove a body tissue. The Ablation Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories ·       The US ·       Europe...
-
Product Insights
SELCHP Plant
SELCHP Plant is a biopower project located in United Kingdom. The project is owned by iCON Infrastructure LLP; Onyx Selchp and was developed by Martin Engineering Co Ltd. The project came online in 1994. Empower your strategies with our SELCHP Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Respiratory Syncytial Virus Clinical Trials Overview The report provides an overview of the Respiratory Syncytial Virus (RSV) clinical trial scenario and top-line data relating to the clinical trials on it. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. Key Regions ·       Asia-Pacific ·       Europe ·       North...
-
Product Insights
Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Interstitial Cystitis Clinical Trials Overview The report provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) clinical trial scenario and top-line data relating to the clinical trials. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. Key Regions ·       North America ·       Asia-Pacific ·       Europe ·       ...
-
Product Insights
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trials Overview The Plaque Psoriasis (Psoriasis Vulgaris) clinical trial report consists of 2018 trials. The report provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) clinical trial scenario. Our study also includes top-line data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). Our analysts have further provided an overview of trial numbers and their average enrolment in top countries conducted across the globe, in this report. Furthermore, our review of the Plaque Psoriasis...